Literature DB >> 302945

Variants of 3T3 cells lacking mitogenic response to epidermal growth factor.

R M Pruss, H R Herschman.   

Abstract

We have previously demonstrated that epidermal growth factor (EGF) can serve as a potent mitogen for 3T3 cells. We have now selected variant 3T3 cell lines unable to respond to EGF, in order to define cellular events unique to the EGF response and to distinguish which of these events are necessary and which are merely correlative to mitogenesis. By simultaneously treating cells with EGF and colchicine, we eliminated those cells stimulated by EGF to enter mitosis. Of the eight clonal EGF nonresponder variants selected by this procedure, none retains a functional EGF receptor. The EGF nonresponsive va-riant lines still retain the ability to respond to other mitogens.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 302945      PMCID: PMC431785          DOI: 10.1073/pnas.74.9.3918

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Response to epidermal growth factors of cultured human mammary epithelial cells from benign tumours.

Authors:  M G Stoker; D Pigott; J Taylor-Papadimitriou
Journal:  Nature       Date:  1976 Dec 23-30       Impact factor: 49.962

3.  Isolation and characterization of revertant cell lines. 3. Isolation of density-revertants of SV40-transformed 3T3 cells using colchicine.

Authors:  A Vogel; R Risser; R Pollack
Journal:  J Cell Physiol       Date:  1973-10       Impact factor: 6.384

4.  Epidermal growth factor: receptors in human fibroblasts and modulation of action by cholera toxin.

Authors:  M D Hollenberg; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

5.  Topoinhibition and serum requirement of transformed and untransformed cells.

Authors:  R Dulbecco
Journal:  Nature       Date:  1970-08-22       Impact factor: 49.962

6.  "Pleiotypic response".

Authors:  A Hershko; P Mamont; R Shields; G M Tomkins
Journal:  Nat New Biol       Date:  1971-08

7.  Specific radiolabeling of a cell surface receptor for epidermal growth factor.

Authors:  M Das; T Miyakawa; C F Fox; R M Pruss; A Aharonov; H R Herschman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

8.  Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes.

Authors:  J G Rheinwald; H Green
Journal:  Nature       Date:  1977-02-03       Impact factor: 49.962

9.  Hormonal stimulation of DNA synthesis in primary cultures of adult rat hepatocytes.

Authors:  R A Richman; T H Claus; S J Pilkis; D L Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

10.  Clonal growth in vitro of human cells with fibroblastic morphology; comparison of growth and genetic characteristics of single epithelioid and fibroblast-like cells from a variety of human organs.

Authors:  T T PUCK; S J CIECIURA; H W FISHER
Journal:  J Exp Med       Date:  1957-07-01       Impact factor: 14.307

View more
  78 in total

1.  E3-13.7 integral membrane proteins encoded by human adenoviruses alter epidermal growth factor receptor trafficking by interacting directly with receptors in early endosomes.

Authors:  D Crooks; S J Kil; J M McCaffery; C Carlin
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

2.  Protein turnover in 3T3 cells transformed with the oncogene c-H-ras1.

Authors:  J M Gunn; G James
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

3.  The role of distinct p185neu extracellular subdomains for dimerization with the epidermal growth factor (EGF) receptor and EGF-mediated signaling.

Authors:  T Kumagai; J G Davis; T Horie; D M O'Rourke; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

4.  Microarchitecture of three-dimensional scaffolds influences cell migration behavior via junction interactions.

Authors:  Brendan A C Harley; Hyung-Do Kim; Muhammad H Zaman; Ioannis V Yannas; Douglas A Lauffenburger; Lorna J Gibson
Journal:  Biophys J       Date:  2008-07-11       Impact factor: 4.033

5.  Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway.

Authors:  Nikolas Balanis; Michael K Wendt; Barbara J Schiemann; Zhenghe Wang; William P Schiemann; Cathleen R Carlin
Journal:  J Biol Chem       Date:  2013-05-07       Impact factor: 5.157

6.  D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.

Authors:  Gabriele Eden; Marco Archinti; Ralitsa Arnaudova; Giuseppina Andreotti; Andrea Motta; Federico Furlan; Valentina Citro; Maria Vittoria Cubellis; Bernard Degryse
Journal:  Cell Mol Life Sci       Date:  2017-11-28       Impact factor: 9.261

7.  Mitogenic signaling from the egf receptor is attenuated by a phospholipase C-gamma/protein kinase C feedback mechanism.

Authors:  P Chen; H Xie; A Wells
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

8.  EGFR Fusions as Novel Therapeutic Targets in Lung Cancer.

Authors:  Kartik Konduri; Jean-Nicolas Gallant; Young Kwang Chae; Francis J Giles; Barbara J Gitlitz; Kyle Gowen; Eiki Ichihara; Taofeek K Owonikoko; Vijay Peddareddigari; Suresh S Ramalingam; Satyanarayan K Reddy; Beth Eaby-Sandy; Tiziana Vavalà; Andrew Whiteley; Heidi Chen; Yingjun Yan; Jonathan H Sheehan; Jens Meiler; Deborah Morosini; Jeffrey S Ross; Philip J Stephens; Vincent A Miller; Siraj M Ali; Christine M Lovly
Journal:  Cancer Discov       Date:  2016-04-21       Impact factor: 39.397

9.  Mechanism of tumor promoter inhibition of cellular binding of epidermal growth factor.

Authors:  L S Lee; I B Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

10.  Malignant transformation of murine fibroblasts by a human c-Ha-ras-1 oncogene does not require a functional epidermal growth factor receptor.

Authors:  I A McKay; P Malone; C J Marshall; A Hall
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.